Skip to main content
. 2021 Jun 23;22(13):6726. doi: 10.3390/ijms22136726

Figure 9.

Figure 9

Knockdown of FRMD5 affects chemoresistance of TPC1 and BCPAP cells. (A) MTS-based analysis of FRMD5-deficient TPC1 and BCPAP cells exposed to doxorubicin (DOX) for 24 h. (B) Representative confocal microscopy images display intracellular DOX accumulation (red signal) in fluorescently labeled (fluorescein isothiocyanate (FITC)-conjugated phalloidin; green signal) cells. Images were recorded using 63×/1.4 oil DIC M27 lens. Cells treated with non-targeting siRNA (siNEG) were used as a control. Graphical data are presented as mean ± SD. ** p < 0.001; *** p < 0.0001.